Vancouver, B.C. – Researchers at the Vancouver Prostate Centre (VPC) have engineered the fastest, artificial intelligence (AI)-enabled technology of its kind to identify novel medications for the SARS-CoV-2 virus. The team’s published study explains how they were able to supercharge the computational screening for potential antiviral compounds more than 100-fold, opening the door to the rapid development of medications to treat infected individuals. 

The Canadian Longitudinal Study on Aging (CLSA) is launching a new project called the Healthy Brains, Health Aging Initiative, which will shed light on the many factors that influence brain health as we age, including lifestyle and the human microbiome.